The Catholic University of Korea, St. Mary's hospital

Seoul 6591

1 studies enrolling now · 7 studies all time

What they study most

Advanced Cholangiocarcinoma, Aspergillosis, FGFR2 Fusions, Gastric Adenocarcinoma, Gastric Cancer, GastroEsophageal Cancer, Gene Rearrangement, HER2-Positive Solid Tumor, Invasive Fungal Infection, Post-essential Thrombocythemia Myelofibrosis, Post-polycythemia Vera Myelofibrosis, Primary Myelofibrosis

Studies at this site

• Study of Futibatinib in Patients With Advanced Cholangiocarcinoma With FGFR2 Fusion or Rearrangement — Recruiting now
• Clinical Trial of YH32367 in Patients With HER2 Positive Locally Advanced or Metastatic Solid Tumor — Recruiting now
• A Phase 3 Study of Pacritinib in Patients With Primary Myelofibrosis, Post Polycythemia Vera Myelofibrosis, or Post-Essential Thrombocythemia Myelofibrosis — Running, not enrolling
• A Study of DKN-01 in Combination With Tislelizumab ± Chemotherapy in Patients With Gastric or Gastroesophageal Cancer — Stopped early
• Isavuconazole (BAL8557) for Primary Treatment of Invasive Aspergillosis — Completed
• A Study of the Safety and Efficacy of GDC-0853 in Participants With Moderate to Severe Active Systemic Lupus Erythematosus — Completed
• A Study of RO4917838 in Participants With Persistent, Predominant Negative Symptoms of Schizophrenia (NN25310) — Completed